MedTrace Logo

Visual Function Abnormalities in Strabismus and Amblyopia and Response to Therapy

NCT04310241 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2026-03-04

No results posted yet for this study

Summary

Amblyopia and strabismus are characterized by a reduction in visual acuity, contrast sensitivity, grating acuity, vernier acuity, reading difficulties and binocular visual function deficits. Treated patients have residual visual function deficits. The purpose of the current study is to quantify various visual functions in amblyopic and strabismic participants at baseline, during and at the completion of treatment.

Conditions

  • Amblyopia
  • Strabismus

Interventions

BEHAVIORAL

Patching therapy, Glasses

Patching, glasses and strabismus surgery are commonly employed measures in treatment of amblyopia and strabismus.

Sponsors & Collaborators

  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Fatema Ghasia, MD · The Cleveland Clinic

Eligibility

Min Age
6 Months
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-21
Primary Completion
2027-03-12
Completion
2027-03-12

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04310241 on ClinicalTrials.gov